Dr. Reddy's Launches Generic Clarinex Reditabs

Dr. Reddy's announced the launch of Desloratadine Orally Disintegrating Tablets (ODT), the generic version of Merck's Clarinex Reditabs. Clarinex is an antihistamine indicated for the treatment of seasonal allergic rhinitis (for patients ≥2 years old), perennial allergic rhinitis, and chronic idiopathic urticaria (for patients ≥6 months old).

Desloratadine is a long-acting tricyclic histamine antagonist with selective H1-activity. Desloratadine is presumed to inhibit histamine release from human mast cells.

Desloratadine ODT is available in 2.5mg and 5mg strengths in 30-count unit dose packages.

For more information call (908) 203-4933 or visit www.drreddys.com